Single Task Exercise Training for Parkinson's (NCT07641569)
Reduce walking problems when multitasking
- Trial ID
- NCT07641569
- Official Title
- Comparison of Motor-Motor and Cognitive-Motor Dual-Task Training in Patients With Parkinson's Disease
- Goal
- Reduce walking problems when multitasking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Saglik Bilimleri Universitesi
- Study Type
- INTERVENTIONAL
- Enrollment
- 39 participants
- Conditions
- Parkinson's Disease (PD)
- Interventions
- Single Task Exercise Training, Motor-Motor Dual Task Exercise Training, Cognitive-Motor Dual Task Exercise Training
- Registry Record Last Updated
- 2026-06-18 (1 month ago)
- Estimated Commitment
- Moderate commitment estimated from the protocol (based on: 45 study visits). This reflects time and procedures only — confirm details with the study coordinator.
Summary For Families
The trial compares two kinds of "dual-task" exercise to see which better helps people with Parkinson's in movement, balance, walking, everyday activities, doing two things at once, thinking during movement, and confidence in balance. One program has people do two physical tasks at once, the other combines a thinking task with a movement task, and both are compared with regular single-task exercise; training is at the clinic twice a week for about 45 minutes each visit for six weeks, with assessments before and after. They are looking for adults age 40 and up who were diagnosed with Parkinson's by a neurologist and are in early to mid stages of the disease, roughly stages 1 to 3 on a common Parkinson's scale. People with other neurological diseases, significant memory or thinking problems (below 24 on the Standardized Mini Mental Test), prior deep brain stimulation surgery, major vision or hearing problems, or orthopedic issues that affect walking and balance are not eligible.
Eligibility at a Glance
Key requirements found in this trial's official criteria, in plain language. Only what the listing states is shown; the study team makes the final call.
- Disease stage: Hoehn and Yahr stage 1 to 3
- Deep brain stimulation: Cannot join after DBS surgery (deep brain stimulation) (criteria text: "exclusion criteria: * presence of a neurological disease other than parkinson's disease * cognitive impairment (standardized mini mental test score less than...")
- Thinking test (MMSE): MMSE memory and thinking score of at least 24 (criteria text: "* Cognitive impairment (Standardized Mini Mental Test score less than 24)")
Do I Likely Qualify? — Self-Check Dimensions
The trial page offers an interactive self-check built from this trial's parsed criteria. It covers these dimensions; anything the criteria don't state clearly is answered "ask the study coordinator", never assumed.
- This trial enrolls people aged 40 or older.
- This trial does not enroll people who have had (or are scheduled for) DBS surgery.
- This trial requires Hoehn and Yahr stage 1 to 3.
- This trial requires an MMSE thinking-test score of at least 24.
Locations
- Gülhane Faculty of Physiotherapy and Rehabilitation, Ankara, Keçiören, Turkey (Türkiye)
Making Contact: How to Call This Study Site
Who to ask for
Ask for the study coordinator. Some sites call this person the research coordinator. They are the right person for questions about joining a study. If you reach a front desk or a doctor's office scheduler, ask them to connect you with the research team for this study.
What to say
It is fine to read this out loud, word for word:
Hello, my name is ____. I am calling about a Parkinson's study at your site. The study number is NCT07641569. It is the one about "Reduce walking problems when multitasking". Could I speak with the study coordinator about taking part?
If you are calling for a family member, use their name and mention that you help with their care.
What they will ask you
- The year of diagnosis
- Current medications and their doses
- Other health conditions
- Any procedures already done, such as deep brain stimulation (DBS)
- How far you are able to travel for study visits
- Whether a care partner can come to visits with you
What to have ready
- A written list of current medications and doses
- Your neurologist's name and phone number
- The diagnosis date. The year is enough.
- A recent visit summary from the neurologist, if you have one
What to ask them
- How many visits are there, and how long does each visit take? The listing already answers this: Participants will receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks, and will participate in assessments at the study clinic before and after exercise training. Ask the coordinator to confirm it still applies.
- Is travel, parking, or my time reimbursed?
- Is there a placebo group, and what is my chance of being in it? The listing already answers this: There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another. Ask the coordinator to confirm it still applies.
- Would I need to stop or pause any of my current medications?
- What happens when the study ends? Could I stay on the treatment if it helps?
What to expect
- Expect to wait a few days for a callback. A week is common. Calling or emailing again after that is fine and normal.
- Many callers do not end up joining. Screening out is common and is not a judgment about you or your health.
- Asking questions commits you to nothing. You can stop the process at any point.
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Single Task Exercise Training. The trial compares two kinds of "dual-task" exercise to see which better helps people with Parkinson's in movement, balance, walking, everyday activities, doing two things at once, thinking during movement, and confidence in balance. One program has people do two physical tasks at once, the other combines a thinking task with a movement task, and both are compared with regular single-task exercise; training is at the clinic twice a week for about 45 minutes each visit for six weeks, with assessments before and after. They are looking for adults age 40 and up who were diagnosed with Parkinson's by a neurologist and are in early to mid stages of the disease, roughly stages 1 to 3 on a common Parkinson's scale. People with other neurological diseases, significant memory or thinking problems (below 24 on the Standardized Mini Mental Test), prior deep brain stimulation surgery, major vision or hearing problems, or orthopedic issues that affect walking and balance are not eligible.
- Who can participate?
- Participants must be at least 40 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- Being asked to pay to join a trial is a red flag: legitimate trials do not charge a participation fee, and the study treatment and study-specific tests are provided by the trial sponsor. What you might still pay depends on where you live: in the US, routine care you would receive anyway can be billed to you or your insurance; trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 3 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- Participants will receive exercise training at the study clinic twice a week for approximately 45 minutes each time, for 6 weeks, and will participate in assessments at the study clinic before and after exercise training.